Ben co-founded Integral Molecular in 2001. He has led all aspects of the company’s growth since its inception, bringing 6 different technologies from research to market and growing the company into a profitable commercial entity. He is an inventor on over 10 of the company’s patents, the principal investigator on over 30 NIH grants, and an author on over 100 publications, including articles published in Cell, Science, and Nature. 

Ben is an established life science entrepreneur, previously responsible for directing the biotechnology program at the Science Center’s business incubator in Philadelphia and helping create startups at the Technology Transfer office at the University of Pennsylvania. He earned a Ph.D. in Cell and Molecular Biology at the University of Pennsylvania, where he led the discovery of the coreceptor CCR5 for HIV. He holds an MBA from the Wharton School of Business, where he co-founded the Penn Biotech Group and won the Wharton business plan competition, and a B.A. from Cornell University. In 2023 he was named CEO of the year in Philadelphia by BioBuzz, and in 2025 he was named CEO of the year in Pennsylvania by Life Sciences PA.